Ketamine clinics have popped up all over country to administer the drug to patients suffering from major depression, bipolar disorder and post-traumatic stress disorder. What benefits can this clinical anesthetic turned street drug provide to those suffering from these conditions?
Most antidepressant drugs target the serotonin system in ways that increase availability of that precious neurotransmitter. Psychiatrists prescribe drugs that either block the breakdown or reuptake of serotonin. The current antidepressant medications work in many cases but not for everyone. Dr. Irving Kirsch and colleagues from Harvard Medical School rehashed old data from a 2008 study, and they found that many antidepressants didn’t have any significant effect compared to a placebo—though these results are still contested.
On the other hand, ketamine affects the brain in a completely different way than classical antidepressants, and researchers do not fully understand it. Many doctors have abandoned standard treatment procedures, starting special clinics that administer single, monitored doses of ketamine. These so-called “ketamine clinics” have popped up all over the country and sometimes sell single administrations of ketamine for up to $1000 per dose. Are these clinics taking advantage of patients in need, or do they really have their patients’ best interests in mind?
While the FDA has not approved the use of ketamine for depression, doctors are permitted to prescribe ketamine to treat any condition as long as they think it’s medically appropriate as an “off-label” use. In this case, ample research does exist to support the use of ketamine for both unipolar and bipolar depression. Due to the fact that treating depression with ketamine is an off-label use, the majority of health insurers will not insure any patient visits to a ketamine clinic.
The treatment programs that ketamine clinics provide hinge on ketamine’s major setback—the duration of efficacy. The anti-depressant and anti-suicidal effects begin as soon as the dissociative effects wear off, but normally only last for about three months. Depending on the patient and the clinic, physicians may prescribe initial repeat doses followed by more infrequent doses at regular intervals.
“Even though the average length of response for an individual is between five and seven days from the single infusion, it is interesting that even at four weeks, more than a third of the people who do respond are seeing a greater than 50 percent reduction in their symptoms,” said Dr. Cole J. Marta from Interventional Psychiatry Associates at the Psychedelic Awareness Salon in Los Angeles.
The appearance of ketamine clinics around the country highlights some of the existing problems in the pharmaceutical market. New, recently developed drugs have marketing and research staffs, who actively promote them to doctors and psychiatrists. Old, off-patent drugs collect dust. In the case of ketamine, new research has surfaced to support its use beyond that of a tranquilizer.
In the case of pharmaceuticals, the grass might not always be greener on the other side; drugs with expired patents may still be useful for a myriad of uninvestigated uses. These old drugs need further research to expand their FDA-approved uses, and physicians need the proper resources to identify the best drug and treatment program for each individual patient.
Pennsylvania Town Decriminalizes Marijuana, Sees Future in Legal Pot
Study Finds Correlation of Daily High Potency Cannabis Use and Mental Illness
National Poll Finds 61 Percent of Americans in Favor of Legalizing Marijuana
For Your Seed and Storage Needs, Try NukeHeads
Knowledgeable Dabbing: A Guide To Our Favorite Quartz Bangers
First Clinical Trial Of Cannabis For PTSD in Veterans Is Now Complete
Missouri Police Raid Hospital Room of Stage 4 Cancer Patient Using Cannabis
Oklahoma House Passes Medical Cannabis Protection Bill
News5 days ago
Indiana State Trooper Seizes $3.5 Million Worth of Cannabis, Vapes
News5 days ago
Colorado Researchers Seeking Volunteers to Get High and Drive
News6 days ago
Study Finds Medical Marijuana Alleviates Seniors’ Pain, Reduces Opioid Use
Legalization6 days ago
Breaking: Connecticut Lawmakers Unveil Plan to Legalize Marijuana
Culture5 days ago
The New “Miss Marijuana” Pageant Comes With Outdated Guidelines and Transphobia
Grow6 days ago
An Interview With Dinafem Seeds: Europe’s King Of Feminized Seeds
News6 days ago
Florida’s Ban on Smokable Marijuana is One Step Closer to Being Repealed
Culture5 days ago
The Family Growing Cannabis to Help People Get Off Pills in Kauai